MoneyWorks4Me

Wockhardt informs about press release

16 Aug 2022 Evaluate

Wockhardt has informed that it enclosed the Press Release titled ‘Wockhardt announces successful initiation of Global Phase 3 Clinical Study of its novel antibiotic WCK 5222’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1763.60
Dr. Reddys Labs. 1264.00
Cipla 1352.65
Lupin 1939.35
Zydus Lifesciences 1156.30
View more..